This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1bx8

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1bx8.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1bx8.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1bx8| PDB=1bx8 | SCENE= }}
{{STRUCTURE_1bx8| PDB=1bx8 | SCENE= }}
-
'''HIRUSTASIN FROM HIRUDO MEDICINALIS AT 1.4 ANGSTROMS'''
+
===HIRUSTASIN FROM HIRUDO MEDICINALIS AT 1.4 ANGSTROMS===
-
==Overview==
+
<!--
-
BACKGROUND: Leech-derived inhibitors have a prominent role in the development of new antithrombotic drugs, because some of them are able to block the blood coagulation cascade. Hirustasin, a serine protease inhibitor from the leech Hirudo medicinalis, binds specifically to tissue kallikrein and possesses structural similarity with antistasin, a potent factor Xa inhibitor from Haementeria officinalis. Although the 2.4 A structure of the hirustasin-kallikrein complex is known, classical methods such as molecular replacement were not successful in solving the structure of free hirustasin. RESULTS: Ab initio real/reciprocal space iteration has been used to solve the structure of free hirustasin using either 1.4 A room temperature data or 1.2 A low temperature diffraction data. The structure was also solved independently from a single pseudo-symmetric gold derivative using maximum likelihood methods. A comparison of the free and complexed structures reveals that binding to kallikrein causes a hinge-bending motion between the two hirustasin subdomains. This movement is accompanied by the isomerisation of a cis proline to the trans conformation and a movement of the P3, P4 and P5 residues so that they can interact with the cognate protease. CONCLUSIONS: The inhibitors from this protein family are fairly flexible despite being highly cross-linked by disulphide bridges. This intrinsic flexibility is necessary to adopt a conformation that is recognised by the protease and to achieve an optimal fit, such observations illustrate the pitfalls of designing inhibitors based on static lock-and-key models. This work illustrates the potential of new methods of structure solution that require less or even no prior phase information.
+
The line below this paragraph, {{ABSTRACT_PUBMED_10368273}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 10368273 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_10368273}}
==About this Structure==
==About this Structure==
Line 34: Line 38:
[[Category: Peptidic inhibitor]]
[[Category: Peptidic inhibitor]]
[[Category: Serine protease inhibitor]]
[[Category: Serine protease inhibitor]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 12:04:19 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 19:51:41 2008''

Revision as of 16:51, 30 June 2008

Template:STRUCTURE 1bx8

HIRUSTASIN FROM HIRUDO MEDICINALIS AT 1.4 ANGSTROMS

Template:ABSTRACT PUBMED 10368273

About this Structure

1BX8 is a Single protein structure of sequence from Hirudo medicinalis. Full crystallographic information is available from OCA.

Reference

The 1.2 A crystal structure of hirustasin reveals the intrinsic flexibility of a family of highly disulphide-bridged inhibitors., Uson I, Sheldrick GM, de La Fortelle E, Bricogne G, Di Marco S, Priestle JP, Grutter MG, Mittl PR, Structure. 1999 Jan 15;7(1):55-63. PMID:10368273

Page seeded by OCA on Mon Jun 30 19:51:41 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools